Wegener granulomatosis - An atypical case

Pediatric Nephrology

Volumn 14, Issue 8-9, 2000, Pages 862-871

  Pradhan, Madhura ^b   Meyers, Kevin E C ^b   Guttenberg, Marta ^b   Kaplan, Bernard S ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b NONE

Author keywords

Anti neutrophilic cytoplasmic antibodies; Small vessel vasculitis; Wegener granulomatosis

Indexed keywords

ANTIBIOTIC AGENT; AZITHROMYCIN; BRONCHODILATING AGENT; CORTICOSTEROID; CYCLOPHOSPHAMIDE; ETHAMBUTOL; ISONIAZID; METHYLPREDNISOLONE SODIUM SUCCINATE; NEUTROPHIL CYTOPLASMIC ANTIBODY; PYRAZINAMIDE; RIFAMPICIN; STEROID;

ACUTE KIDNEY FAILURE; ADOLESCENT; ARTICLE; CASE REPORT; CLINICAL FEATURE; FEMALE; GLOMERULONEPHRITIS; GRANULOMA; GRANULOMATOUS VASCULITIS; HEMODIALYSIS; HUMAN; HUMAN TISSUE; LUNG HEMORRHAGE; LUNG TUBERCULOSIS; MYCOBACTERIUM INTRACELLULARE AVIUM; OPEN LUNG BIOPSY; PRIORITY JOURNAL; RESPIRATORY FAILURE; WEGENER GRANULOMATOSIS;

EID: 0033929383     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00013445     Document Type: Article

References (61)

1. Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, Hagen EC, Hoffman GS, Hunder GG, Kallenberg CG, McCluskey RT, Sinico RA, Rees AJ, Es LA van, Waldherr R, Wiik A (1994) Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 37:187-192
2. Jennette JC, Falk RJ (1994) The pathology of vasculitis involving the kidney. Am J Kidney Dis 24:130-141
3. Falk RJ, Jennette JC (1998) ANCA with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N Engl J Med 318:1651-1657
4. Hagen EC, Ballieux Be, Van Es La, Daha MR, Woude FJ van der (1993) Antineutrophilic cytoplasmic autoantibodies: a review of the antigens, the assays, and the clinical and possible pathogenetic consequences. Blood 81:1996-2008
5. Falk RJ, Jennette JC (1997) ANCA small vessel vasculitis. J Am Soc Nephrol 8:315-322
6. D'Amico G, Sinico A, Ferrario F (1996) Renal vasculitis. Nephol Dial Transplant 11 [Suppl 9]:69-74
7. Jennette JC, Wilkman AS, Tuttle RH, Falk RJ (1996) How pauci-immune is ANCA associated crescentic glomerulonephritis (abstract)? J Am Soc Nephrol 7:1735
8. Short AK, Esnnault VL, Lockwood CM (1995) ANCA and anti-GBM antibodies: two co-existing distinct auto-reactivities detectable in patients with RPGN. Am J Kidney Dis 26:439-445
9. Dillon MJ, Ansell BM (1995) Vasculitis in children and adolescents. Rheum Dis North Am 21:1115-1135
10. Rottem M, Fauci AS, Hallahan CW, Kerr GS, Lebovics R, Leavitt R, Hoffman GS (1993) Wegener's granulomatosis in children and adolescents: clinical presentation and outcome. J Pediatr 122:26-31
11. Jennette JC, Falk RJ (1998) Pathogenesis of the vascular and glomerular damage in ANCA- positive vasculitis. Nephrol Dial Transplant 13:16-20
12. Kallenberg CGM, Brouwer E, Weening JJ, Cohen Tervaert JW (1994) ANCA: current diagnostic and pathophysiologic potential. Kidney Int 46:1-15
13. Jennette JC, Falk RJ (1994) Pathogenic potential of ANCA. Lab Invest 70:1135-1137
14. Brouwer E, Huitema MG, Klok PA, De Weerd H, Cohen Tervaert JW, Weening JJ, Kallenberg CGM (1993) Antimyeloperoxidase-associated proliferative glomerulonephritis - an animal model. J Exp Med 177:905-914
15. Kobayashi K, Shibata T, Sugisaki T (1995) Aggravation of rat nephrotoxic serum nephritis by anti-myeloperoxidase antibodies. Kidney Int 47:454
16. Herringa P, Brouwer E, Klok PA, Huitema MG, Born van dem, Weening JJ, Kallenberg CGM (1996) Autoantibodies to myeloperoxidase aggravate mild anti-glomeular-basement membrane-mediated glomerular injury in the rat. Am J Pathol 149:1695-1706
17. Gilligan HM, Bredy B, Brady HR, Hebert MJ, Slayter HS, Xu YH, Rauch J, Shia MA, Koh JS, Leveine JS (1996) Antineutrophil cytoplasmic autoantibodies interact with primary granule constituents on the surface of apoptotic neutrophils in the absence of neutrophil priming. J Exp Med 184:2231-2241
18. Porges AJ, Redecha PB, Kimberly WT, Csernok E, Gross WL, Kimberly RP (1994) Anti-neutrophil cytoplasmic antibodies engage and activate human neutrophils via Fc gamma RIIa. J Immunol 153:1271-1280
19. Savage COS, Pottinger BE, Gaskin G, Pusey CD, Pearson JD (1992) Autoantibodies developing to myeloperoxidase and proteinase 3 in systemic vasculitis stimulate neutrophil cytotoxicity toward cultured endothelial cells. Am J Pathol 141: 335-342
20. Cockwell P, Brooks CJ, Adu D, Savage Cos (1999) A pathogenetic role in antineutrophil cytoplasmic autoantibody (ANCA)-associated glomerulonephritis. Kidney Int 55:852-863
21. Salant DJ (1999) ANCA: fuel for the fire or the spark that ignites the flame? Kidney Int 55:1125-1127
22. Cohen Tervaert JW, Huitema MG, Hene RJ, Sluiter WJ (1990) Prevention of relapses in WG by treatment based on ANCA titers. Lancet 336:709-711
23. Jayne DRW, Gaskin G, Pusey CD, Lockwood CM (1995) ANCA and predicting relapse in systemic vasculitis. Q J Med 88:127-133
24. Cohen Tervaert JW, Woude FJ van der, Fauci AS, Ambrus JL, Velosa J, Keane WF, Meijer S, Giessen M van der, Hem GK van der, The TH (1989) Association between active Wegener's granulomatosis and ANCA. Arch Intern Med 149:2461-2465
25. Reinhold-Keller E, Kekow J, Schnabel A, Schmitt WH, Heller M, Beigel A, Duncker G, Gross WL (1994) Influence of disease manifestation and ANCA titer in the response to pulse cyclophosphamide therapy in patients with WG. Arthritis Rheum 37:919-924
26. Gaudin PB, Askin FB, Falk RJ, Jennette JC (1995) The pathologic spectrum of pulmonary lesions in patients with ANCA specific for anti-proteinase 3 and antimyeloperoxidase. Am J Clin Pathol 104:7-16
27. Bosch X, Lopez-Soto A, Mirapiex E (1994) ANCA-associated alveolar capillaritis in patients presenting with pulmonary hemorrhage. Arch Pathol Lab Med 118:517-518
28. Hoffman GS, Kerr GS, Leavitt RY, Hallahan CW, Lebovics S, Travis WD, Rottem M, Fauci AS (1992) Wegener's granulomatosis: an analysis of 158 patients. Ann Intern Med 116:488-498
29. Woodworth TG, Abuelo GJ, Austin HA III, Esparaza A (1987) Severe glomerulonephritis with late emergence of classic Wegener's granulomatosis. Medicine (Baltimore) 66:181-191
30. Appel GB, Gee B, Kashgarian M, Hayslett JP (1981) Wegener's granulomatosis: clinico-pathologic correlations and long term course. Am J Kidney Dis 1:27-37
31. Fauci AS, Haynes BF, Katz P, Wolff SM (1983) Wegener's granulomatosis prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med 98:76-85
32. Kuross S, Davin T, Kjellstrand CM (1981) Wegener's granulomatosis with severe renal failure. Clinical course and results of dialysis and transplantation. Clin Nephrol 16:172-180
33. Cuevas J, Pelegri A, Morlans M, Fort J, Bonal J, Piera L (1982) Wegener's granulomatosis and hemodialysis. Clin Nephrol 18:109
34. Pinching AJ, Lockwood CM, Pussell BA, Rees AJ, Sweny P, Evans DJ, Bowley N, Peters DK (1983) Wegener's granulomatosis: observations on 18 patients with severe renal disease. Q J Med 52:435-460
35. Casciani CU, DeDimone C, Bonini S, Gallucci MT, Matteucci G, Valesini G, Meli D, Masala C (1978) Immunologic aspects of chronic uremia. Kidney Int [Suppl] 13:S49-S54
36. Goldblum SE, Reed WP (1980) Host defenses and immunologic alterations associated with chronic hemodialysis. Ann Intern Med 93:597-613
37. Revillard JP (1979) Immunologic alterations in chronic renal insufficiency. Adv Nephrol 8:365-382
38. Haubitz M, Koch KM, Brunkhorst R (1998) Survival and vasculitis activity in patients with end-stage renal disease due to Wegener's granulomatosis. Nephrol Dial Transplant 13:1713-1718
39. Pusey CD, Rees AJ, Evans DJ, Peters DK, Lockwood CM (1991) Plasma exchange in focal necrotizing glomerulonephritis without anti-GBM antibodies. Kidney Int 40:757-763
40. Falk RJ, Hogan S, Carey TS, Jennette JC (1990) Clinical course of ANCA-associated glomerulonephritis and systemic vasculitis; The Glomerular Disease Collaborative Network. Ann Intern Med 113:656-663
41. Nachman PH, Hogan SL, Jennette JC, Falk RJ (1996) Treatment response and relapse in ANCA-associated microscopic polyangiitis and glomerulonephritis. J Am Soc Nephrol 7:23-32
42. Schmitt WH, Gross WL (1998) Vasculitis in the seriously ill patient: diagnostic approaches and therapeutic options in ANCA-associated vasculitis. Kidney Int 53 [Suppl 64]:S39-S44
43. Talar-Williams C, Hijazi Y, Walther M, Lineham WM, Hallahan CW, Lubensky I, Kerr GS, Hoffman GS, Fauci AS, Sneller MC (1996) Cyclophosphamide-induced cystitis and bladder cancer in patients with Wegener's granulomatosis. Ann Intern Med 124:477-484
44. Haubitz M, Frei U, Rother U, Brunkhorst R, Koch KM (1991) Cyclophosphamide pulse therapy in Wegener's granulomatosis. Nephrol Dial Transplant 6:531-535
45. Adu D, Pall A, Luqmani RA, Richards NT, Howie AJ, Emery P, Michael J, Savage CO, Bacon PA (1997) Controlled trial of pulse versus continuous prednisolone and cyclophoshamide in the treatment of systemic vasculitis. Q J Med 90:401-409
46. Haubitz, M, Ehlerding C, Kamino K, Koch KM, Brunkhorst R (1998) Reduced gonadal toxicity after i.v. cyclophosphamide administration in patients with nonmalignant diseases. Clin Nephrol 49:19-23
47. Hoffman GS, Leavitt RY, Kerr GS, Fauci AS (1992) The treatment of Wegener's granulomatosis with glucocorticoids and methotrexate. Arthritis Rheum 35:1322-1329
48. De Renee RA, McDonald TJ, Weiland LH (1985) Wegener's granulomatosis: observations on treatment with anti-microbial agents. Mayo Clin Proc 60:27-32
49. Stegemann CA, Cohen-Tervaert JW, Sluiter WJ, Manson WL, Jong PE, Kallenberg CGM (1994) Association of chronic nasal carriage of Staphylococcus aureus and higher relapse rates in Wegener's granulomatosis. Ann Intern Med 120:12-17
50. Reinhold-Keller E, De Groot K, Rudert H, Nolle B, Heller M, Gross WL (1996) Response to trimethoprim-sulfamethoxazole in Wegener's granulomatosis depends on the phase of the disease. Q J Med 89:15-23
51. Stegemann CA, Cohen Tervaert JW, Jong PE de, Kallenberg CGM (1996) Trimethoprim-sulfamethoxazole for the prevention of relapses on Wegener's granulomatosis. N Engl J Med 335:16-20
52. De Groot K, Reinhold-Keller E, Tastis E, Paulsen J, Heller M, Nolle B, Gross WL (1996) Therapy for maintenance of remission in 65 patients with generalized Wegener's granulomatosis. Methotrexate versus trimethoprim/sulphamethoxazole. Arthritis Rheum 39:2052-2061
53. Steinman TI, Joffe BF, Monaco AP, Wolff S, Fauci AS (1980) Recurrence of Wegener's granulomatosis after kidney transplantation: successful reinduction of remission with cyclophosphamide. Am J Med 68:450-468
54. Toussaint C, Thoou Y, Goldman M, De Paww L, Catalano C, Veereeerstraeten P (1989) Early renal graft failure due to recurrence of Wegener's granulomatosis under cyclosporine therapy. Clin Transplant 3:27-31
55. Clarke AE, Bitten A, Eappen R, Danoff DS, Esdaile JN (1990) Treatment of Wegener's granulomatosis after transplantation: is cyclosporine the preferred treatment? Transplantation 50: 1047-1051
56. Schmitt WA, Haubitz M, Mistry N, Brunkhorst R, Erbsloh-Moller B, Gross WL (1993) Renal transplantation in Wegener's granulomatosis. Lancet 342:860
57. Rostaing L, Modesto A, Oksman F, Cistern JM, Le Mao G, Durtand D (1997) Outcome of patients with anti-neutrophil cytoplasmic autoantibody-associated vasculitis following cadaveric kidney transplantation. Am J Kidney Dis 29:96-102
58. Wrenger E, Pirsch JD, Cangro CB, D'Alessandro AM, Knechtle SJ, Kalayoglu M, Sollinger HW (1997) Single-center experience with renal transplantation in patients with Wegener's granulomatosis. Transpl Int 10:152-156
59. MarchevskyA, Damsker B, Gribetz A, Tepper S, Geller S (1982) The spectrum of pathology of nontuberculous mycobacterial infections in open-lung biopsy specimens. Am J Clin Pathol 78:695-700
60. Kerr GR, Fleischer THA, Hallahan CW, Leavitt RY, Fauci AS, Hoffman GS (1993) Limited prognostic value of changes in antineutrophil cytoplasmic antibody titer in patients with Wegener's granulomatosis. Arthritis Rheum 36:365-371
61. Nowack R, Birck R, Woude FJ van der (1997) Mycophenolate mofetil for systemic vasculitis and IgA nephropathy. Lancet 349:774